Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.930
-0.140-1.39%
Volume:45.90M
Turnover:453.22M
Market Cap:114.41B
PE:24.97
High:10.040
Open:9.955
Low:9.670
Close:10.070
52wk High:10.720
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:0.55
T/O Rate:0.40%
Dividend:0.29
Dividend Rate:2.92%
EPS(LYR):0.398
ROE:20.90%
ROA:10.70%
PB:2.60
PE(LYR):24.97
PS:3.12

Loading ...

CSPC Pharmaceutical - Sys6057 Receives Nmpa Approval on July 30, 2026 to Conduct Clinical Trials in China

THOMSON REUTERS
·
Aug 25

Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$10.93 From HK$10.31, Keeps at Buy

MT Newswires Live
·
Aug 24

CSPC Pharmaceutical Group Stock Climbs 2.2% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 24

Daiwa Raises CSPC Pharma Target Price to HK$11.2 on In-Line Interim Results

Stock News
·
Aug 24

Movement Alert|CSPC PHARMA Rises 4.46% in Regular Trading, Multiple Investment Banks Raise Target Prices Post-Earnings

Market Focus
·
Aug 24

BofA Securities Lifts CSPC Pharma Target Price to HK$8.6 While Maintaining Underperform Rating

Deep News
·
Aug 23

UBS Lifts CSPC Pharma Price Target to HK$11.80, Reiterates Buy Rating

Deep News
·
Aug 23

Goldman Sachs Adjusts CSPC Pharma Target Price Upward While Retaining Buy Stance

Deep News
·
Aug 23

CSPC Pharmaceutical Group Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.
·
Aug 23

China's Haohai Biological H1 Revenue Falls, Partly Hurt by End of Brighten Optix Distribution

Reuters
·
Aug 21

UOB Kay Hian Upgrades CSPC Pharmaceutical Group to Buy from Sell; Price Target is HK$11.50

MT Newswires Live
·
Aug 21

Goldman Sachs Raises CSPC Pharma Price Target to HK$12.56, Reaffirms Buy Rating

Stock News
·
Aug 21

CSPC Pharmaceutical Group Stock Falls 3.5% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 21

美银证券上调石药集团目标价至8.6港元,维持“跑输大市”评级

Stock News
·
Aug 21

Morgan Stanley Raises CSPC Pharma Target Price to HK$12, Maintains Overweight Rating

Stock News
·
Aug 21

Movement Alert|CSPC PHARMA Declines 3.05% in Regular Trading, Northbound Profit-Taking Follows Post-Earnings Rally

Market Focus
·
Aug 21

China's Simcere Pharmaceutical H1 Revenue Rises on Neuroscience, Autoimmune Drugs Strength

Reuters
·
Aug 20

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

Southbound Capital Daily: Net Selloff Hits HK$10.41B, Alibaba Draws Mainland Buying Pre-Earnings, Healthcare Stocks Split

Stock News
·
Aug 20

Hong Kong Stocks Rise on Thursday on Easing Bond Concerns, Tech Gains; CSPC Pharma Jumps 9%

MT Newswires Live
·
Aug 20